Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema

Table 1

Demographic and anamnestic data, follow-up times and safety findings.

Number	Eye	Gender	Age at cataract surgery	Femto- assisted cataract surgery	Implanted IOL	Further previous eye surgeries	Previous treatment	Beginning of symptoms after cataract surgery (days)
1	Right	Female	78	No	Polytech H10 ASP +23.0 dpt	None	Topical diclofenac/; oral acetazolamide	48
2	Right	Female	80	No	n/a	Intravitreal avastin	Topical diclofenac	31
3	Left	Female	62	No	Polytech AS61+28.5 dpt	None	Topical diclofenac/; oral acetazolamide	86
4	Left	Female	82	No	Polytech AS61+11.0 dpt	IOL repositioning	Topical diclofenac/; oral acetazolamide	16
5	Right	Female	53	Yes	Polytech H10 ASP+20.5 dpt	None	Topical diclofenac/; oral acetazolamide	63
6	Left	Male	63	Yes	AMO Tecnis +21.0 dpt	None	Topical diclofenac/; local dorzolamide	46
7	Right	Male	76	No	Asphina 409 MP 21.5 dpt	None	Topical diclofenac/; local dorzolamide	17
8	Left	Female	77	No	Polytech H10 ASP +25.0 dpt	None	Topical diclofenac/; oral acetazolamide	8
9	Left	Female	68	No	STAAR KS-Xs+22.5 dpt	None	Topical diclofenac/; oral acetazolamide	61
10	Right	Female	65	No	Euromaxx N313+18.5 dpt	None	Topical diclofenac/; oral acetazolamide	93
11	Right	Female	73	Yes	Euromaxx N313+22.5 dpt	None	Topical diclofenac/; oral acetazolamide	7
12	Left	Male	62	Yes	Asphina 409 MP +20.5 dpt	Vitrectomy	Topical diclofenac/; oral acetazolamide	36
13	Right	Female	76	No	Asphina 409 MP+20.5 dpt	None	Topical diclofenac/; local dorzolamide	46
14	Left	Male	67	Yes	ZXRoo+23.0 dpt	None	Topical diclofenac/; oral acetazolamide	35
15	Left	Female	75	No	Euromaxx AL1313Y +23.5 dpt	None	Topical diclofenac/; oral acetazolamide	55
16	Left	Male	78	No	Polytech H11+23.0 dpt	Focal argon laser coagulaton	Topical diclofenac/; oral acetazolamide	84
17	Right	Male	62	No	Asphina 409 MP 20.0 dpt	None	Topical diclofenac/; oral acetazolamide	14
18	Right	Male	61	No	n/a	None	Topical diclofenac	16
19	Right	Female	64	No	n/a	IOL sulcus implantation + vitrectomy	Topical prednisolone/; oral prednisolone	42

The table summarizes patient parameter as well as cataract surgery specific parameter from all 19 patients included in this study. All patients who experienced a CFT reduction more than 200 μm have been marked bold in this table.